RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR |
|---|---|---|
| $2.6B | +39.7% | 28.0% |
| Shareholders' equity (Q2 2026) | $2.6B |
|---|---|
| YoY | +39.7% |
| 5-year CAGR | 28.0% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $1.6B | −28.0% |
| 2024 | $2.3B | +24.0% |
| 2023 | $1.8B | +166.5% |
| 2022 | $685M | +13.7% |
| 2021 | $603M | +26.9% |
| 2020 | $475M | — |
| 2019 | −$153M | — |
| 2018 | −$108M | — |